Lilly has the edge on Danish rival Novo to weather potential U.S. price cuts on its blockbuster obesity drug Zepbound, backed ...

"The labour market is soft. Employment gains in September followed two months of sizeable losses. Job losses have been ...

OTTAWA, Oct 29 (Reuters) - The Bank of Canada on Wednesday slashed its growth forecasts for both 2025 and 2026, citing the ...

(Reuters) -Life sciences group Thermo Fisher is nearing an all-cash takeover of drug trial software maker Clario in a deal ...

MATT BRITZMAN, SENIOR EQUITY ANALYST, HARGREAVES LANSDOWN THAT HOLDS SHARES IN NVIDIA"Nvidia hitting a $5 trillion market cap ...

(Reuters) -GPS device maker Garmin on Wednesday raised its adjusted profit forecast for the year, but reported a rise in ...

LONDON (Reuters) -Britain's Prime Minister Keir Starmer on Wednesday declined to commit to a previous pledge not to raise ...

NEW YORK (Reuters) -The U.S. Department of Labor has been sued by former Morgan Stanley financial advisers for allegedly ...

LONDON (Reuters) -Apollo Global Management, Blackstone and Ares Management had no exposure to U.S. companies First Brands and ...

The company raised its forecast for annual adjusted profit per share to between $5.22 and $5.26, compared with its earlier ...

Bulled up by another wave of AI deal-making and earnings excitement and with interest rates about to fall again, Wall Street ...

(Reuters) -Boeing reported a charge of nearly $5 billion related to delays in its 777X jet program on Wednesday.